TNFα antagonists in rheumatoid arthritis patients seen in everyday practice

被引：15

作者：

Falgarone, Geraldine ^{[1
]}

Duclos, Muriel ^{[2
]}

Boissier, Marie-Christophe ^{[2
]}

机构：

[1] Hop Avicenne, Serv Rhumatol, CHU Avicenne, F-93009 Bobigny, France

[2] Univ Paris 13, INSERM ER118, Avicenne Teaching Hosp, Rheumatol Dept,AP HP, Bobigny, France

来源：

JOINT BONE SPINE | 2007年 / 74卷 / 06期

关键词：

TNF alpha antagonists; real-world practice; everyday practice; rheumatoid arthritis;

D O I：

10.1016/j.jbspin.2007.10.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：523 / 526

页数：4

共 35 条

[21] Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial [J].

Klareskog, L ;

van der Heijde, D ;

de Jager, JP ;

Gough, A ;

Kalden, J ;

Malaise, M ;

Mola, EM ;

Pavelka, K ;

Sany, J ;

Settas, L ;

Wajdula, J ;

Pedersen, R ;

Fatenejad, S ;

Sanda, M .

LANCET, 2004, 363 (9410) :675-681

[22] Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis.: Results from a six-year observational study in southern Sweden [J].

Kristensen, Lars Erik ;

Saxne, Tore ;

Nilsson, Jan-Ake ;

Geborek, Pierre .

ARTHRITIS RESEARCH & THERAPY, 2006, 8 (06)

[23] Anti-tumor necrosis factor-alpha therapy in the ordinary clinical setting: Three-year effectiveness in patients with rheumatoid arthritis [J].

Kvalvik, Anne Grimstvedt ;

Lefsaker, Liv ;

Dyvik, Siri ;

Brun, Johan Gorgas .

JOINT BONE SPINE, 2007, 74 (06) :606-611

[24] Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints:: a comparison with the original DAS remission [J].

Landewé, R ;

van der Heijde, D ;

van der Linden, S ;

Boers, M .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (05) :637-641

[25] Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan [J].

Matsui, Toshihiro ;

Kuga, Yoshiaki ;

Kaneko, Atsushi ;

Nishino, Jinju ;

Eto, Yoshito ;

Chiba, Noriyuki ;

Yasuda, Masayuki ;

Saisho, Koichiro ;

Shimada, Kota ;

Tohma, Shigeto .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1221-1226

[26] Safety of infliximab and other biologic agents in the inflammatory bowel diseases [J].

Reddy, Jagadeshwar G. ;

Loftus, Edward V., Jr. .

GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (04) :837-+

[27] Infections during tumour necrosis factor-α blocker therapy for rheumatic diseases in daily practice:: a systematic retrospective study of 709 patients [J].

Salliot, C. ;

Gossec, L. ;

Ruyssen-Witrand, A. ;

Luc, M. ;

Duclos, M. ;

Guignard, S. ;

Dougados, M. .

RHEUMATOLOGY, 2007, 46 (02) :327-334

[28]

Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3

[29] Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor α agents in rheumatoid arthritis [J].

Sokka, T ;

Pincus, T .

ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :313-318

[30] Infliximab continuation rates in patients with rheumatoid arthritis in everyday practice [J].

Wendling, D ;

Materne, GE ;

Michel, F ;

Lohse, A ;

Lehuede, G ;

Toussirot, E ;

Massol, J ;

Woronoff-Lemsi, MC .

JOINT BONE SPINE, 2005, 72 (04) :309-312

← 1 2 3 4 →